Lipid-Based Drug Delivery: Dosage Form Design from Preclinical to First-in-Human
January
10

Lipid-Based Drug Delivery: Dosage Form Design from Preclinical to First-in-Human

 January 10, 2023 

Online


A high proportion of new drug candidates never reach market due to poor solubility, which limits their potential for absorption. As such, the solubility and permeability of an active pharmaceutical ingredient (API) are the driving forces behind bioavailability. In order to avoid development challenges and delays, it is critical to fully explore these parameters when developing formulations to enhance and maximise oral bioavailability. Lipid-based drug delivery systems offer a way to effectively deliver poorly soluble or bioavailable drugs in both preclinical and human studies. The physicochemical characteristics of the API determine if lipid delivery is an appropriate approach for dosage form design.

Read on xtalks.dryfta.com

Continue reading at

Interested in this event?


Next Event

  • January
    10

    Fierce JPM Week

     January 10, 2023 

    Fairmont San Francisco, 950 Mason Street, San Francisco, California, 94108, United States

    Fierce JPM Week

Medigy Innovation Network

Connecting innovation decision makers to authoritative information, institutions, people and insights.

Medigy Logo

The latest News, Insights & Events

Medigy accurately delivers healthcare and technology information, news and insight from around the world.

The best products, services & solutions

Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.


© 2024 Netspective Foundation, Inc. All Rights Reserved.

Built on Nov 5, 2024 at 4:53am